ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors

Shahrukh K. Hashmi, Stephanie J. Lee, Bipin N. Savani, Linda Burns, John R. Wingard, Miguel Angel Perales, Jeanne Palmer, Eric Chow, Everett Meyer, David Marks, Mohamad Mohty, Yoshihiro Inamoto, Cesar Rodriguez, Arnon Nagler, Craig Sauter, Krishna V. Komanduri, Joseph Pidala, Mehdi Hamadani, Laura Johnston, Nina Shah & 11 others Paul Shaughnessy, Betty K. Hamilton, Navneet Majhail, Mohamed A. Kharfan-Dabaja, Jeff Schriber, Zachariah DeFilipp, Katherine G. Tarlock, Suzanne Fanning, Peter Curtin, J. Douglas Rizzo, Paul A. Carpenter

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Significant advances in hematopoietic cell transplantation (HCT) have increased the long-term survivorship of its recipients, but because of unique complications arising from radiation and chemotherapy, recipients require lifelong follow-up. To evaluate current survivorship or long-term follow-up (LTFU) clinics specifically for HCT survivors and to evaluate the potential barriers in their establishment, the American Society for Blood and Marrow Transplantation (ASBMT) Practice Guidelines Committee electronically surveyed 200 HCT programs to gather quantitative and qualitative data about models of care. Among 77 programs (38.5%) that responded, 45% indicated presence of an LTFU clinic; however, LTFU care models varied with respect to services provided, specialist availability, type of patients served, and staffing. Among 55% of programs without an LTFU clinic, 100% agreed that allogeneic HCT survivors have unique needs separate from graft-versus-host disease and that complications could arise during the transition of care either from pediatric to adult settings or away from the HCT center. Lack of expertise, logistics, financial issues, and the observation that 84% of individual practitioners prefer to provide survivorship care were the identified obstacles to establishing new LTFU clinics. The ASBMT hopes that policymakers, HCT providers, and institutions will benefit from the results of this survey and recommends that delivering guidelines-driven screening and expert management of late effects is the goal of first-rate HCT survivorship care.

Original languageEnglish (US)
Pages (from-to)1119-1124
Number of pages6
JournalBiology of Blood and Marrow Transplantation
Volume24
Issue number6
DOIs
StatePublished - Jun 1 2018

Fingerprint

Cell Transplantation
Practice Guidelines
Survivors
Transplantation
Bone Marrow
Transplants
Survival Rate
Patient Transfer
Aftercare
Graft vs Host Disease
Surveys and Questionnaires
Guidelines
Radiation
Pediatrics
Drug Therapy

Keywords

  • Long-term
  • Survivor
  • Transplant

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Hashmi, S. K., Lee, S. J., Savani, B. N., Burns, L., Wingard, J. R., Perales, M. A., ... Carpenter, P. A. (2018). ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors. Biology of Blood and Marrow Transplantation, 24(6), 1119-1124. https://doi.org/10.1016/j.bbmt.2018.03.023

ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors. / Hashmi, Shahrukh K.; Lee, Stephanie J.; Savani, Bipin N.; Burns, Linda; Wingard, John R.; Perales, Miguel Angel; Palmer, Jeanne; Chow, Eric; Meyer, Everett; Marks, David; Mohty, Mohamad; Inamoto, Yoshihiro; Rodriguez, Cesar; Nagler, Arnon; Sauter, Craig; Komanduri, Krishna V.; Pidala, Joseph; Hamadani, Mehdi; Johnston, Laura; Shah, Nina; Shaughnessy, Paul; Hamilton, Betty K.; Majhail, Navneet; Kharfan-Dabaja, Mohamed A.; Schriber, Jeff; DeFilipp, Zachariah; Tarlock, Katherine G.; Fanning, Suzanne; Curtin, Peter; Rizzo, J. Douglas; Carpenter, Paul A.

In: Biology of Blood and Marrow Transplantation, Vol. 24, No. 6, 01.06.2018, p. 1119-1124.

Research output: Contribution to journalArticle

Hashmi, SK, Lee, SJ, Savani, BN, Burns, L, Wingard, JR, Perales, MA, Palmer, J, Chow, E, Meyer, E, Marks, D, Mohty, M, Inamoto, Y, Rodriguez, C, Nagler, A, Sauter, C, Komanduri, KV, Pidala, J, Hamadani, M, Johnston, L, Shah, N, Shaughnessy, P, Hamilton, BK, Majhail, N, Kharfan-Dabaja, MA, Schriber, J, DeFilipp, Z, Tarlock, KG, Fanning, S, Curtin, P, Rizzo, JD & Carpenter, PA 2018, 'ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors', Biology of Blood and Marrow Transplantation, vol. 24, no. 6, pp. 1119-1124. https://doi.org/10.1016/j.bbmt.2018.03.023
Hashmi, Shahrukh K. ; Lee, Stephanie J. ; Savani, Bipin N. ; Burns, Linda ; Wingard, John R. ; Perales, Miguel Angel ; Palmer, Jeanne ; Chow, Eric ; Meyer, Everett ; Marks, David ; Mohty, Mohamad ; Inamoto, Yoshihiro ; Rodriguez, Cesar ; Nagler, Arnon ; Sauter, Craig ; Komanduri, Krishna V. ; Pidala, Joseph ; Hamadani, Mehdi ; Johnston, Laura ; Shah, Nina ; Shaughnessy, Paul ; Hamilton, Betty K. ; Majhail, Navneet ; Kharfan-Dabaja, Mohamed A. ; Schriber, Jeff ; DeFilipp, Zachariah ; Tarlock, Katherine G. ; Fanning, Suzanne ; Curtin, Peter ; Rizzo, J. Douglas ; Carpenter, Paul A. / ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors. In: Biology of Blood and Marrow Transplantation. 2018 ; Vol. 24, No. 6. pp. 1119-1124.
@article{8e83615d0513427891a6fe457682cad6,
title = "ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors",
abstract = "Significant advances in hematopoietic cell transplantation (HCT) have increased the long-term survivorship of its recipients, but because of unique complications arising from radiation and chemotherapy, recipients require lifelong follow-up. To evaluate current survivorship or long-term follow-up (LTFU) clinics specifically for HCT survivors and to evaluate the potential barriers in their establishment, the American Society for Blood and Marrow Transplantation (ASBMT) Practice Guidelines Committee electronically surveyed 200 HCT programs to gather quantitative and qualitative data about models of care. Among 77 programs (38.5{\%}) that responded, 45{\%} indicated presence of an LTFU clinic; however, LTFU care models varied with respect to services provided, specialist availability, type of patients served, and staffing. Among 55{\%} of programs without an LTFU clinic, 100{\%} agreed that allogeneic HCT survivors have unique needs separate from graft-versus-host disease and that complications could arise during the transition of care either from pediatric to adult settings or away from the HCT center. Lack of expertise, logistics, financial issues, and the observation that 84{\%} of individual practitioners prefer to provide survivorship care were the identified obstacles to establishing new LTFU clinics. The ASBMT hopes that policymakers, HCT providers, and institutions will benefit from the results of this survey and recommends that delivering guidelines-driven screening and expert management of late effects is the goal of first-rate HCT survivorship care.",
keywords = "Long-term, Survivor, Transplant",
author = "Hashmi, {Shahrukh K.} and Lee, {Stephanie J.} and Savani, {Bipin N.} and Linda Burns and Wingard, {John R.} and Perales, {Miguel Angel} and Jeanne Palmer and Eric Chow and Everett Meyer and David Marks and Mohamad Mohty and Yoshihiro Inamoto and Cesar Rodriguez and Arnon Nagler and Craig Sauter and Komanduri, {Krishna V.} and Joseph Pidala and Mehdi Hamadani and Laura Johnston and Nina Shah and Paul Shaughnessy and Hamilton, {Betty K.} and Navneet Majhail and Kharfan-Dabaja, {Mohamed A.} and Jeff Schriber and Zachariah DeFilipp and Tarlock, {Katherine G.} and Suzanne Fanning and Peter Curtin and Rizzo, {J. Douglas} and Carpenter, {Paul A.}",
year = "2018",
month = "6",
day = "1",
doi = "10.1016/j.bbmt.2018.03.023",
language = "English (US)",
volume = "24",
pages = "1119--1124",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors

AU - Hashmi, Shahrukh K.

AU - Lee, Stephanie J.

AU - Savani, Bipin N.

AU - Burns, Linda

AU - Wingard, John R.

AU - Perales, Miguel Angel

AU - Palmer, Jeanne

AU - Chow, Eric

AU - Meyer, Everett

AU - Marks, David

AU - Mohty, Mohamad

AU - Inamoto, Yoshihiro

AU - Rodriguez, Cesar

AU - Nagler, Arnon

AU - Sauter, Craig

AU - Komanduri, Krishna V.

AU - Pidala, Joseph

AU - Hamadani, Mehdi

AU - Johnston, Laura

AU - Shah, Nina

AU - Shaughnessy, Paul

AU - Hamilton, Betty K.

AU - Majhail, Navneet

AU - Kharfan-Dabaja, Mohamed A.

AU - Schriber, Jeff

AU - DeFilipp, Zachariah

AU - Tarlock, Katherine G.

AU - Fanning, Suzanne

AU - Curtin, Peter

AU - Rizzo, J. Douglas

AU - Carpenter, Paul A.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Significant advances in hematopoietic cell transplantation (HCT) have increased the long-term survivorship of its recipients, but because of unique complications arising from radiation and chemotherapy, recipients require lifelong follow-up. To evaluate current survivorship or long-term follow-up (LTFU) clinics specifically for HCT survivors and to evaluate the potential barriers in their establishment, the American Society for Blood and Marrow Transplantation (ASBMT) Practice Guidelines Committee electronically surveyed 200 HCT programs to gather quantitative and qualitative data about models of care. Among 77 programs (38.5%) that responded, 45% indicated presence of an LTFU clinic; however, LTFU care models varied with respect to services provided, specialist availability, type of patients served, and staffing. Among 55% of programs without an LTFU clinic, 100% agreed that allogeneic HCT survivors have unique needs separate from graft-versus-host disease and that complications could arise during the transition of care either from pediatric to adult settings or away from the HCT center. Lack of expertise, logistics, financial issues, and the observation that 84% of individual practitioners prefer to provide survivorship care were the identified obstacles to establishing new LTFU clinics. The ASBMT hopes that policymakers, HCT providers, and institutions will benefit from the results of this survey and recommends that delivering guidelines-driven screening and expert management of late effects is the goal of first-rate HCT survivorship care.

AB - Significant advances in hematopoietic cell transplantation (HCT) have increased the long-term survivorship of its recipients, but because of unique complications arising from radiation and chemotherapy, recipients require lifelong follow-up. To evaluate current survivorship or long-term follow-up (LTFU) clinics specifically for HCT survivors and to evaluate the potential barriers in their establishment, the American Society for Blood and Marrow Transplantation (ASBMT) Practice Guidelines Committee electronically surveyed 200 HCT programs to gather quantitative and qualitative data about models of care. Among 77 programs (38.5%) that responded, 45% indicated presence of an LTFU clinic; however, LTFU care models varied with respect to services provided, specialist availability, type of patients served, and staffing. Among 55% of programs without an LTFU clinic, 100% agreed that allogeneic HCT survivors have unique needs separate from graft-versus-host disease and that complications could arise during the transition of care either from pediatric to adult settings or away from the HCT center. Lack of expertise, logistics, financial issues, and the observation that 84% of individual practitioners prefer to provide survivorship care were the identified obstacles to establishing new LTFU clinics. The ASBMT hopes that policymakers, HCT providers, and institutions will benefit from the results of this survey and recommends that delivering guidelines-driven screening and expert management of late effects is the goal of first-rate HCT survivorship care.

KW - Long-term

KW - Survivor

KW - Transplant

UR - http://www.scopus.com/inward/record.url?scp=85046667868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046667868&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2018.03.023

DO - 10.1016/j.bbmt.2018.03.023

M3 - Article

VL - 24

SP - 1119

EP - 1124

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 6

ER -